Stay updated on Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Sign up to get notified when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new published version of the page.
    Difference
    0.1%
    Check dated 2026-08-11T16:37:36.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, with the previous Revision: v3.6.3 removed. This is a minor page update and does not modify the study content or functionality.
    Difference
    0.1%
    Check dated 2026-07-28T05:27:17.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page, marking a new revision of the study record. This change represents a metadata update and does not alter the visible content or functionality of the page.
    Difference
    0.1%
    Check dated 2026-07-06T16:40:56.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The revision tag on the page has been updated from v3.6.0 to v3.6.2, signaling a platform/documentation update. It does not affect the study content or patient information presented on the page.
    Difference
    0.1%
    Check dated 2026-06-29T08:50:58.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    No additions or deletions were provided in the website_changes data, so there is no change to describe. The page content remains unchanged based on the supplied input.
    Difference
    0.1%
    Check dated 2026-06-22T05:24:45.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Recruitment status updated to no longer looking for participants, indicating enrollment has ended. Minor UI and informational updates include new/renamed navigation items and help sections, plus a revision label.
    Difference
    0.5%
    Check dated 2026-06-15T08:20:38.000Z thumbnail image

Stay in the know with updates to Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.